Skip over generic navigation
Skip over primary navigation
Skip over visual
Skip over functional column
Curt Brahn opened his own correspondent office in Shanghai under the name “Degussa C. Brahn Correspondence,” located in 133, Yuen Ming Yuen Road. This office was entrusted with the entire product range of Degussa and individual subsidiaries, though it did not sell the products itself. The correspondent office provided technical support for customers of Degussa products and was also responsible for initiating new business contacts.
Degussa China Ltd. was established in Hong Kong for the sale and distribution of Degussa goods and commercial products in Hong Kong, Macau, and China.
Degussa has been producing specialty chemical products in the Greater China region since the late 1970’s when the company entered the precipitation silica patented manufacturing agreement with United Silica Industrial Ltd. in Taiwan.
The foundation stone was laid in the Xinzhuang Industrial Park in Shanghai.
Degussa (China) Co., Ltd. was established in Beijing as the umbrella company for the Group’s chemicals activities in the region. It has provided the resources and competencies required to support the profitable growth of our businesses in China.
Degussa AG opened a research and development center in Shanghai, with a total investment of over €12 million. To facilitate the establishment of new business activities in China, in 2004 we embarked on the construction of a multi-user site (MUSC) in Shanghai Chemical Industry Park (SCIP).
Production sites have been rapidly expanded all over the Greater China region.
Due to the formation of Evonik Industries AG from sections of the RAG Group and Degussa AG, the former Degussa (China) Co. Ltd., China was renamed Evonik Degussa (China) Co. Ltd.
In September, Evonik held the groundbreaking ceremony for the integrated production plant for the manufacture of methyl methacrylates (MMA) and methacrylate specialties in SCIP, with a volume of€250 million.
The Shanghai R&D center was expanded by adding 15, 000 m² with an investment of over €10mio.
Evonik achieved sales target of €1 billion in the Greater China region.
The startup of the integrated Methyl Methacrylate Production Facility was successfully completed in February.
In September, Evonik Tianda (Liaoyang) Chemical Additive Co., Ltd. moved into Liaoyang National Aromatic and Fine Chemical High-Tech Industrial Zone.
Evonik announced to invest more than €350 million in the construction of new production capacities for specialty chemicals in China. In parallel with the expansion of local production capacities, Evonik was significantly increasing its innovation activities in Asia. €23 million was being invested in further expansion of the Group’s R&D Center in Shanghai.In April, Evonik’s first project house outside Germany was established in Taiwan.
In June, Evonik laid the foundation stone for the new isophorone and isophorone diamine plants in SCIP.
In October, Evonik marked the roof-topping phase of construction for its hydrogen peroxide plant in Jilin, China.
In October, Evonik launch the start-up for the new organic production facility in SCIP for cosmetic and household products as well as industrial applications based on renewable resources.
The new research and development building is inaugurated. This is the third expansion of our R&D center in Shanghai since its opening in 2004. The rapidly increasing demand for R&D facilities in Shanghai reflects our strong focus on ‘innovation in China for China’.
In July, Evonik commenced isophorone facilities in China, which would primarily serve customers in the coatings and paint, construction, adhesives, and composite industry in Asia.
Evonik opened its new ROHACELL® plant in Shanghai in January, providing innovative structural foam products used worldwide in a variety of industries including aviation, automotive, electronics, medical and sports equipment. In March, Evonik started the construction of a new specialty silicones production facility in China, as part of a global investment initiative. The completion of the facility is planned for mid of 2017.